M&A Deal Summary

Codexis Acquires Biocatalytics

On July 19, 2007, Codexis, Inc. acquired chemicals company Biocatalytics, Inc.

Acquisition Highlights
  • This is Codexis’ 2nd transaction in the Chemicals sector.
  • This is Codexis’ 1st transaction in the United States.
  • This is Codexis’ 1st transaction in California.

M&A Deal Summary

Date 2007-07-19
Target Biocatalytics, Inc.
Sector Chemicals
Buyer(s) Codexis, Inc.
Deal Type Add-on Acquisition

Target

Biocatalytics, Inc.

Pasadena, California, United States
Biocatalytics, Inc. is a private company that has produced custom and off-the-shelf enzymes used in chemical process manufacturing by pharmaceutical and fine chemical companies.

Search 137,550 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial, then $150/Month

Buyer(S) 1

Buyer

Codexis, Inc.

Redwood City, California, United States

website


Category Company
Founded 2002
SectorLife Science
Employees132
Revenue 61M USD (2018)
DESCRIPTION

Codexis, Inc. is a developer of biocatalysts or enzymes that initiate and accelerate a chemical reaction. Codexis' technologies bring improved manufacturing approaches to sectors ranging from the pharmaceutical industry, fine chemicals, flavors and fragrances, to animal health, food and nutrition, agrochemicals and carbon capture. Codexis was formed in 2002 and is based in Redwood City, California.


DEAL STATS #
Overall 2 of 2
Sector (Chemicals) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (California) 1 of 1
Country (United States) 1 of 1
Year (2007) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-02-22 Julich Fine Chemicals GmbH

Jülich, Germany

Julich Fine Chemicals GmbH (JFC) is a supplier of specialty enzymes (biocatalysts) for organic synthesis and chiral building blocks to pharmaceutical and chemical companies worldwide. JFC offers a wide range of off-the-shelf specialty enzymes and chiral intermediates useful in pharmaceutical development.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-03-17 Codexis Laboratories Hungary Kft.

Budapest, Hungary

Codexis Laboratories Hungary Kft. operates a biocatalysts research and development facility.

Sell -